Stay updated on DAPA-MI Trial: Dapagliflozin Post Heart Attack
Sign up to get notified when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.

Latest updates to the DAPA-MI Trial: Dapagliflozin Post Heart Attack page
- CheckyesterdayChange DetectedThe record history shows the revision label updated from v3.6.3 to v3.6.4. This indicates a new platform version was applied.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe revision identifier in the record history was updated from v3.6.2 to v3.6.3. This indicates a minor page update that does not alter the study details or results.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page history shows a newer revision label (v3.6.2) replacing the previous v3.6.0, indicating a deployment update to the ClinicalTrials.gov record history interface. This change updates the version display but does not alter the underlying study data or history records.SummaryDifference0.1%

- Check44 days agoChange DetectedDifference0.3%

- Check51 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing v3.5.4 and reflecting a new site version.SummaryDifference0.1%

- Check72 days agoChange DetectedThe Record History now shows a new revision, v3.5.4, replacing the previous v3.5.3. This reflects an update to the study record's history metadata.SummaryDifference0.1%

Stay in the know with updates to DAPA-MI Trial: Dapagliflozin Post Heart Attack
Enter your email address, and we'll notify you when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.